Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AHGNYSEAMERICAN:CTMNASDAQ:MXCTNYSE:SHAP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAHGAkso Health Group$1.47-15.5%$1.31$0.62▼$2.35$253.56M-0.1968,809 shs12,938 shsCTMCastellum$0.99-2.0%$0.99$0.12▼$2.83$69.21M-12.753.74 million shs1.23 million shsMXCTMaxCyte$2.30-0.4%$2.53$2.10▼$5.26$245.60M1.38600,810 shs1.15 million shsSHAPSpree Acquisition Corp. 1$10.91$10.91$10.35▼$11.93$283.07M-0.0231,316 shsN/A7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAHGAkso Health Group0.00%-17.42%+5.00%+8.89%+31.25%CTMCastellum0.00%-3.92%+4.17%-8.37%+299.03%MXCTMaxCyte0.00%+5.02%-17.56%-31.14%-50.85%SHAPSpree Acquisition Corp. 10.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAHGAkso Health Group0.7609 of 5 stars0.05.00.00.02.90.00.0CTMCastellum2.9253 of 5 stars3.54.00.00.03.22.50.0MXCTMaxCyte2.5681 of 5 stars3.52.00.00.02.72.50.6SHAPSpree Acquisition Corp. 1N/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAHGAkso Health Group 0.00N/AN/AN/ACTMCastellum 3.00Buy$3.00203.15% UpsideMXCTMaxCyte 3.00Buy$7.50226.09% UpsideSHAPSpree Acquisition Corp. 1 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest CTM, SHAP, AHG, and MXCT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/24/2025CTMCastellumMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy$3.004/24/2025CTMCastellumMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy$3.004/23/2025CTMCastellumUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong Sell ➝ Hold3/12/2025MXCTMaxCyteBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy ➝ Buy$6.003/12/2025MXCTMaxCyteStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$11.00 ➝ $9.00(Data available from 6/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAHGAkso Health Group$8.45M25.34N/AN/A$0.95 per share1.55CTMCastellum$45.24M1.53$0.02 per share50.69$0.27 per share3.67MXCTMaxCyte$37.68M6.49N/AN/A$2.23 per share1.03SHAPSpree Acquisition Corp. 1N/AN/AN/AN/A($0.47) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAHGAkso Health Group-$9.46MN/A0.00∞N/AN/AN/AN/AN/ACTMCastellum-$17.80M-$0.17N/A∞N/A-20.69%-75.58%-31.71%8/7/2025 (Estimated)MXCTMaxCyte-$37.92M-$0.40N/AN/AN/A-78.36%-16.00%-13.93%8/5/2025 (Estimated)SHAPSpree Acquisition Corp. 1$4.35MN/A0.00∞N/AN/A-22.17%6.72%N/ALatest CTM, SHAP, AHG, and MXCT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025MXCTMaxCyte-$0.10-$0.10N/A-$0.10$9.05 million$10.39 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAHGAkso Health GroupN/AN/AN/AN/AN/ACTMCastellumN/AN/AN/AN/AN/AMXCTMaxCyteN/AN/AN/AN/AN/ASHAPSpree Acquisition Corp. 1N/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAHGAkso Health GroupN/AN/AN/ACTMCastellum0.631.111.11MXCTMaxCyteN/A9.819.22SHAPSpree Acquisition Corp. 1N/A6.196.19Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAHGAkso Health Group1.21%CTMCastellum3.39%MXCTMaxCyte68.81%SHAPSpree Acquisition Corp. 19.94%Insider OwnershipCompanyInsider OwnershipAHGAkso Health GroupN/ACTMCastellum45.55%MXCTMaxCyte3.00%SHAPSpree Acquisition Corp. 158.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAHGAkso Health Group40145.72 millionN/ANot OptionableCTMCastellum20769.94 million38.08 millionNot OptionableMXCTMaxCyte80106.32 million102.67 millionOptionableSHAPSpree Acquisition Corp. 1N/A25.95 million10.79 millionNot OptionableCTM, SHAP, AHG, and MXCT HeadlinesRecent News About These CompaniesSenior journalist Kandula Subramaniam passes awayNovember 5, 2024 | exchange4media.come4m Confluence - The Media Investments Summit to explore the future of brands & agenciesOctober 31, 2024 | exchange4media.comCapella Space Awarded Hybrid Acquisition for Proliferated LEO Contract by the Space Development AgencyOctober 23, 2024 | businesswire.comCT manufacturer reports record quarterly sales amid acquisition spree; stock price up 45% since start of yearOctober 23, 2024 | hartfordbusiness.comStripe in $1.1B Acquisition Deal for Stablecoin Platform BridgeOctober 22, 2024 | msn.comPermira completes Squarespace acquisition after upping bid to $7.2BOctober 17, 2024 | techcrunch.comNixxy's Acquisition Spree Heats Up: Shoots For $1B ValuationOctober 17, 2024 | benzinga.comAnticipated Private Equity Acquisition of Bausch + Lomb Corporation Offers Attractive Upside for InvestorsOctober 16, 2024 | markets.businessinsider.comParen Secures $3M in Seed Funding alongside Acquisition of EVAdoption LLC to Power Unified Electric MobilityOctober 3, 2024 | tmcnet.comNew Hawaiian Airlines CEO shares what's on the horizon following acquisitionSeptember 20, 2024 | bizjournals.comHawaiian Air interim CEO details what's next following landmark acquisitionSeptember 19, 2024 | hawaiinewsnow.comLaunch One Acquisition Corp. Cl ASeptember 10, 2024 | wsj.comJournalist Reveals the Real Reasons Behind Chelsea’s ‘Heavy’ Spending SpreeSeptember 5, 2024 | sports.yahoo.comGlobal borrowing blitz led by blue chips selling $43bnSeptember 4, 2024 | moneyweb.co.zaGlobal Borrowing Blitz Led by Blue Chips Selling $43 BillionSeptember 4, 2024 | finance.yahoo.comLaunch One Acquisition Corp. - Ordinary Shares - Class ASeptember 4, 2024 | money.usnews.comUS Pipeline Deals Will Pick Up Speed Following ONEOK’s SpreeSeptember 4, 2024 | bloomberg.comWaterbury manufacturer, on acquisition spree, buys 2nd company in 3 monthsAugust 22, 2024 | hartfordbusiness.comBoost for Rachel Reeves as borrowing costs fallAugust 14, 2024 | finance.yahoo.comDatabricks reportedly paid $2 billion in Tabular acquisitionAugust 14, 2024 | techcrunch.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCTM, SHAP, AHG, and MXCT Company DescriptionsAkso Health Group NASDAQ:AHG$1.47 -0.27 (-15.52%) Closing price 05/30/2025 03:57 PM EasternExtended Trading$1.53 +0.06 (+4.15%) As of 05/30/2025 05:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.Castellum NYSEAMERICAN:CTM$0.99 -0.02 (-2.02%) Closing price 05/30/2025 04:10 PM EasternExtended Trading$0.98 -0.01 (-0.97%) As of 05/30/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Castellum, Inc. provides services in the areas of cybersecurity, information technology, electronic and information warfare, and information operations. Its services include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and model based systems engineering services. It serves customers in the federal government, financial services, healthcare, and other data application sectors. The company is based in Bethesda, Maryland.MaxCyte NASDAQ:MXCT$2.30 -0.01 (-0.43%) Closing price 05/30/2025 04:00 PM EasternExtended Trading$2.38 +0.08 (+3.48%) As of 05/30/2025 06:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.Spree Acquisition Corp. 1 NYSE:SHAP$10.91 0.00 (0.00%) As of 05/30/2025Spree Acquisition Corp. 1 Limited does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the mobility-related technology businesses. The company was incorporated in 2021 and is based in Atlanta, Georgia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/26 - 05/30 Super Micro Computer Stock Finding Upside With NVIDIA's Blackwell Ackman Takes a Swing at Amazon — Should You? Taiwan Semiconductor: Time to Buy After Strong NVIDIA Results? Intel’s Turnaround May Be the Best Bet No One’s Watching Nike’s Amazon Expansion Could Signal a Turnaround in 2025 ASML Stock Might Be the Safest Chip Play at This Price Archer Aviation Stock Steadies After Short-Seller Report Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
